340B purchases hit $66.3B in 2023

(By Alexandra Murphy for Becker’s Hospital Review)

A total of $66.3 billion in outpatient drugs was purchased through the 340B drug pricing program in 2023, according to data from the Health Resources and Services Administration released Oct. 21. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.